Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Inflammatory eye disorders
•
Pediatric Rheumatology
What is your recommended rheumatic disease evaluation for a pediatric patient presenting with interstitial keratitis and a negative infectious disease workup (e.g., HSV, syphilis, Lyme)?
Related Questions
What is your approach to treatment in patients with cutaneous mastocytosis and inflammatory arthritis?
In a patient with isolated HLA B27+ anterior uveitis, how long would you continue immunosuppressive therapy?
Should the age at which patients transition from pediatric to adult care differ depending on the disease diagnosis?
How do you approach treatment of tuberculous scleritis in pregnancy?
How would you approach the management of HLA-B27-associated recurrent uveitis and inflammatory back pain with a recent history of melanoma?
How do you discuss sexual health with pediatric patients transitioning to adult rheumatology care when the patient is accompanied by parents or caregiver?
What are some of the biggest challenges you run into when patients transition from pediatric to adult care?
What are some strategies to help teach patients transitioning from pediatric to adult care to become more independent with respect to their care and less dependent on their caregivers?
Do you recommend adjusted adult cancer screening for patients who have been on long term biologics and/or tsDMARDs since childhood?
Is there a benefit to having a transition period in which a patient continues following with their previous pediatric rheumatologist while establishing care with a new adult rheumatologist?
